DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling.
Times cited: 21
Epigenetic regulators and their impact on therapy in acute myeloid leukemia.
Times cited: 9
Next-generation sequencing and detection of minimal residual disease in acute myeloid leukemia: Ready for clinical practice?.
JAMA - Journal of the American Medical Association.
Times cited: 4